{"id":151936,"date":"2017-02-07T01:06:04","date_gmt":"2017-02-07T01:06:04","guid":{"rendered":"http:\/\/healthmedicinet.com\/i\/a-bridge-to-breathing\/"},"modified":"2017-02-07T01:06:04","modified_gmt":"2017-02-07T01:06:04","slug":"a-bridge-to-breathing","status":"publish","type":"post","link":"http:\/\/healthmedicinet.com\/i\/a-bridge-to-breathing\/","title":{"rendered":"A bridge to breathing"},"content":{"rendered":"<p>PITTSBURGH (February 6, 2017) &#8230; Acute and chronic lung diseases are the most life-threatening causes of hospitalization and death among young children. This is especially true for children suffering from cystic fibrosis. The path to recovery often leads to a lung transplant, but the wait list for pediatric patients can last for months and require lengthy hospital stays anchored to large mechanical ventilators.<\/p>\n<p>To safely bridge the time between diagnosis and transplant while allowing patient mobility, a research team led by the University of Pittsburgh&#8217;s Swanson School of Engineering, working with the McGowan Institute for Regenerative Medicine, is developing a compact respiratory assist device for children. The Pittsburgh Pediatric Ambulatory Lung (P-PAL) would replace traditional oxygenation methods as a bridge to transplant or recovery in children with lung failure.<\/p>\n<p>The proposal, &#8220;Ambulatory Assist Lung for Children,&#8221; was the recipient of a four-year, $2,357,508 R01 award from the National Institute of Health&#8217;s National Heart, Lung, And Blood Institute. Program Director\/Principal Investigator is William J. Federspiel, Professor in the Swanson School&#8217;s Department of Bioengineering. Co-PIs are William R. Wagner, Director of the McGowan Institute for Regenerative Medicine and Professor of Surgery, Bioengineering and Chemical Engineering at Pitt; and Peter D. Wearden, congenital cardiothoracic surgeon and Department Chair, Division of Cardiovascular Surgery, Department of Cardiovascular Services at the Nemours Children&#8217;s Health System, Orlando, Florida.<\/p>\n<p>&#8220;Standard existing therapy not only restricts children&#8217;s mobility in the hospital but can also cause lung damage and\/or worsening of the child&#8217;s health,&#8221; Dr. Federspiel explains. &#8220;Our new approach allows the patient&#8217;s lungs to rest and heal, and if the child is a candidate for lung transplantation, the mobility afforded by the P-PAL will lead to better post-transplant outcomes.&#8221;<\/p>\n<p>One of P-PAL&#8217;s most innovative features is that it will allow young patients to remain mobile in the hospital while under treatment or awaiting transplant. &#8220;Pediatric patients can still be active children, and at young ages you don&#8217;t want to restrict them to a hospital bed,&#8221; Dr. Wagner said. &#8220;The P-PAL is a self-contained, minimally-invasive device that can provide children with mobility even while awaiting a transplant.&#8221;<\/p>\n<p>Co-investigators on the award include Jonathan D&#8217;Cunha, Associate Professor of Surgery in the Department of Cardiothoracic Surgery at Pitt, and Greg W. Burgreen, Associate Research Professor at the Mississippi State University Bagley College of Engineering.<\/p>\n<p align=\"center\">###<\/p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PITTSBURGH (February 6, 2017) &#8230; Acute and chronic lung diseases are the most life-threatening causes of hospitalization and death among young children. This is especially true for children suffering from cystic fibrosis. The path to recovery often leads to a lung transplant, but the wait list for pediatric patients can last for months and require <a class=\"read-more-link\" href=\"http:\/\/healthmedicinet.com\/i\/a-bridge-to-breathing\/\">Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-151936","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/posts\/151936","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/comments?post=151936"}],"version-history":[{"count":0,"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/posts\/151936\/revisions"}],"wp:attachment":[{"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/media?parent=151936"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/categories?post=151936"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/healthmedicinet.com\/i\/wp-json\/wp\/v2\/tags?post=151936"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}